Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.850
-0.040 (-2.12%)
At close: Feb 25, 2026, 4:00 PM EST
1.830
-0.020 (-1.08%)
After-hours: Feb 25, 2026, 5:14 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Drug Delivery Systems
217.76K832.01K10.26M1.77M7.41M
Drug Delivery Systems Growth
-73.83%-91.89%478.23%-76.05%80.24%
Total
217.76K832.01K10.26M1.77M7.41M
Total Growth
-73.83%-91.89%478.23%-76.05%80.24%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States
217.76K832.01K10.26M1.77M7.41M
United States Growth
-73.83%-91.89%478.23%-76.05%80.24%
Total
217.76K832.01K10.26M1.77M7.41M
Total Growth
-73.83%-91.89%478.23%-76.05%80.24%
Source: S&P Global Market Intelligence.